In this context, it is expected that on-target toxicity might be significant for this therapy.
← all excerpts
SETD8 inhibition targets cancer cells with increased rates of ribosome biogenesis.
1
—
—
In this context, it is expected that on-target toxicity might be significant for this therapy.